InsiderClue
Insiders · Profile

VIKING GLOBAL INVESTORS LP

10% owner at Inhibrx Biosciences · 10% owner at BridgeBio Pharma · 10% owner at APi · and 10 more. Filing since 2 Oct 2014. CIK 0001103804

INBX Inhibrx Biosciences, Inc. 10% owner · 1 trade BBIO BridgeBio Pharma, Inc. 10% owner · 4 trades APG APi Group Corp 10% owner · 3 trades FDMT 4D Molecular Therapeutics, Inc. 10% owner · 3 trades ROIV Roivant Sciences Ltd. 10% owner · 1 trade AMLX Amylyx Pharmaceuticals, Inc. 10% owner · 3 trades PRCT PROCEPT BioRobotics Corp 10% owner · 2 trades FIGS FIGS, Inc. 10% owner · 2 trades RLYB Rallybio Corp 10% owner · 1 trade ADPT Adaptive Biotechnologies Corp 10% owner · 4 trades ZNTL Zentalis Pharmaceuticals, Inc. 10% owner · 2 trades EDIT Editas Medicine, Inc. 10% owner · 2 trades W Wayfair Inc. 10% owner · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
INBX Inhibrx Biosciences, Inc.
7 Oct 2025
10% owner
Sold at will
350,000
$11.29M
83.9%
BBIO BridgeBio Pharma, Inc.
27 Jun 2025
10% owner
Sold at will
3,500,000
$154.00M
15.9%
BBIO BridgeBio Pharma, Inc.
31 Jan 2025
10% owner
Sold at will
3,065,616
$106.99M
12.2%
APG APi Group Corp
17 Jun 2024
10% owner
Sold at will
3,903,564
$148.92M
100%
APG APi Group Corp
5 Mar 2024
10% owner
Sold at will
6,077,234
$208.15M
99.4%
FDMT 4D Molecular Therapeutics, Inc.
4 Jan 2024
10% owner
Sold at will
540,000
$10.55M
11.3%
APG APi Group Corp
2 Jan 2024
10% owner
Sold at will
13,000,000
$406.90M
99.9%
BBIO BridgeBio Pharma, Inc.
18 Jul 2023
10% owner
Sold at will
1,500,000
$52.50M
5.6%
ROIV Roivant Sciences Ltd.
22 Jun 2023
10% owner
Sold at will
13,000,000
$128.70M
95.3%
FDMT 4D Molecular Therapeutics, Inc.
9 May 2023
10% owner
Bought
850,000
$13.60M
21.6%
AMLX Amylyx Pharmaceuticals, Inc.
9 Sep 2022
10% owner
Sold, plan not stated
700,000
$21.16M
27.4%
AMLX Amylyx Pharmaceuticals, Inc.
8 Sep 2022
10% owner
Sold, plan not stated
700,000
$20.56M
25.2%
PRCT PROCEPT BioRobotics Corp
18 Mar 2022
10% owner
Sold, plan not stated
1,249,000
$37.35M
80.7%
AMLX Amylyx Pharmaceuticals, Inc.
11 Jan 2022
10% owner
Bought
2,300,000
$43.70M
opened
PRCT PROCEPT BioRobotics Corp
17 Sep 2021
10% owner
Bought
400,000
$14.00M
opened
FIGS FIGS, Inc.
3 Sep 2021
10% owner
Sold, plan not stated
42,413
$1.91M
0.3%
FIGS FIGS, Inc.
2 Sep 2021
10% owner
Sold, plan not stated
157,587
$7.45M
1.1%
RLYB Rallybio Corp
29 Jul 2021
10% owner
Bought
806,000
$10.48M
23.8%
FDMT 4D Molecular Therapeutics, Inc.
15 Dec 2020
10% owner
Bought
1,100,000
$25.30M
38.8%
ADPT Adaptive Biotechnologies Corp
14 Dec 2020
10% owner
Sold, plan not stated
1,000,000
$55.65M
3.2%
ZNTL Zentalis Pharmaceuticals, Inc.
1 Dec 2020
10% owner
Sold, plan not stated
500,000
$25.25M
11.3%
ADPT Adaptive Biotechnologies Corp
11 Nov 2020
10% owner
Sold, plan not stated
2,500,000
$123.79M
7.5%
ZNTL Zentalis Pharmaceuticals, Inc.
7 Apr 2020
10% owner
Bought
725,000
$13.05M
19.5%
ADPT Adaptive Biotechnologies Corp
28 Jan 2020
10% owner
Sold, plan not stated
4,912,899
$122.71M
12.8%
ADPT Adaptive Biotechnologies Corp
1 Jul 2019
10% owner
Bought
250,000
$5.00M
17.5%
BBIO BridgeBio Pharma, Inc.
27 Jun 2019
10% owner
Bought
4,705,900
$80.00M
21.5%
EDIT Editas Medicine, Inc.
8 Feb 2015
10% owner
Bought
1,020,407
no price
opened
EDIT Editas Medicine, Inc.
8 Feb 2015
10% owner
Bought
1,020,407
no price
59.7%
W Wayfair Inc.
20 Nov 2014
10% owner
Bought
17,600
$400.03K
3.4%
W Wayfair Inc.
20 Nov 2014
10% owner
Bought
17,600
$400.03K
1.0%
W Wayfair Inc.
7 Nov 2014
10% owner
Bought
22,500
no price
4.5%
W Wayfair Inc.
7 Nov 2014
10% owner
Bought
22,500
no price
1.3%
W Wayfair Inc.
3 Nov 2014
10% owner
Bought
1,200
$30.20K
0.2%
W Wayfair Inc.
3 Nov 2014
10% owner
Bought
1,200
$30.20K
0.1%
W Wayfair Inc.
2 Oct 2014
10% owner
Bought
479,250
no price
37.7%
W Wayfair Inc.
2 Oct 2014
10% owner
Bought
105,461
no price
32.8%
36 decisions on file.